Enhancement of adenovirus infection in WI-38 and AGMK cells by pretreatment of cells with 5-iododeoxyuridine.
D000256:Adenoviridae / Q000254:growth & development* / Q000276:immunology; D000818:Animals; D002460:Cell Line; D003561:Cytarabine / Q000494:pharmacology; D003588:Cytopathogenic Effect, Viral; D004247:DNA / Q000096:biosynthesis; D005455:Fluorescent Antibody Technique; D000882:Haplorhini; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007065:Idoxuridine / Q000378:metabolism / Q000494:pharmacology*; D007668:Kidney; D008168:Lung / Q000196:embryology; D013539:Simian virus 40 / Q000254:growth & development; D010948:Viral Plaque Assay; D014779:Virus Replication / Q000187:drug effects
D006649:Histocompatibility Antigens; D003561:Cytarabine; D004247:DNA; D007065:Idoxuridine